Breaking New Ground in Bioconjugate Innovation

Pearl River Laboratories continues to proactively monitor emerging trends and innovations in the bioconjugate space.

We are proud to announce that we have been granted licenses by New York State and the U.S. Drug Enforcement Administration (DEA) for controlled substance activity. These licenses allow Pearl River Labs to research and develop bioconjugates containing controlled substances, including antibody-steroid conjugates.

With a dedicated laboratory buildout for controlled substances, coupled with our existing bioconjugate platforms, we are now equipped to support bioconjugate programs across multiple modalities with the highest standards of compliance, safety, and scientific rigor.

Contact us: https://lnkd.in/efUbYMHc